🚀 VC round data is live in beta, check it out!
Cell Impact Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cell Impact and similar public comparables like Mangels, Coil, Nordic Flanges Group, Pipe Works L Girakian and more.
Cell Impact Overview
About Cell Impact
Cell Impact develops technologies to produce flow plates for fuel cells. It provides graphite, stainless steel, and titanium flow plates. The company has developed and patented a method for high-velocity forming, Cell Impact Forming that makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional molding methods. Geographically, it operates in Sweden, Asia, U.S. and Other Europe.
Founded
1999
HQ
Employees
41
Website
Sectors
Financials (FY)
EV
$10M
Cell Impact Financials
Cell Impact reported last fiscal year revenue of $606K and negative EBITDA of ($6M).
In the same fiscal year, Cell Impact generated ($553K) in gross profit, ($6M) in EBITDA losses, and had net loss of ($14M).
Cell Impact P&L
In the most recent fiscal year, Cell Impact reported revenue of $606K and EBITDA of ($6M).
Cell Impact expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $606K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($553K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (91%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($6M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (982%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (2296%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($14M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (2370%) | XXX | XXX | XXX |
| Net Debt | — | — | $547K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cell Impact Stock Performance
Cell Impact has current market cap of $8M, and enterprise value of $10M.
Market Cap Evolution
Cell Impact's stock price is $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10M | $8M | -7.1% | XXX | XXX | XXX | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCell Impact Valuation Multiples
Cell Impact trades at 16.1x EV/Revenue multiple, and (1.6x) EV/EBITDA.
Cell Impact Financial Valuation Multiples
As of April 22, 2026, Cell Impact has market cap of $8M and EV of $10M.
Equity research analysts estimate Cell Impact's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cell Impact has a P/E ratio of (0.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV (current) | $10M | XXX | $10M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 16.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1.6x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (0.7x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (17.7x) | XXX | XXX | XXX |
| P/E | — | XXX | (0.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (1.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cell Impact Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cell Impact Margins & Growth Rates
Cell Impact's revenue in the last fiscal year declined by (85%).
Cell Impact's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Cell Impact Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (85%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (982%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (18%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 2205% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cell Impact Public Comps
See public comps and valuation multiples for other Metals & Mining comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cell Impact | XXX | XXX | XXX | XXX | XXX | XXX |
| Mangels | XXX | XXX | XXX | XXX | XXX | XXX |
| Coil | XXX | XXX | XXX | XXX | XXX | XXX |
| Nordic Flanges Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Pipe Works L Girakian | XXX | XXX | XXX | XXX | XXX | XXX |
| Lovisagruvan | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cell Impact M&A Activity
Cell Impact acquired XXX companies to date.
Last acquisition by Cell Impact was on XXXXXXXX, XXXXX. Cell Impact acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cell Impact
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCell Impact Investment Activity
Cell Impact invested in XXX companies to date.
Cell Impact made its latest investment on XXXXXXXX, XXXXX. Cell Impact invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cell Impact
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cell Impact
| When was Cell Impact founded? | Cell Impact was founded in 1999. |
| Where is Cell Impact headquartered? | Cell Impact is headquartered in Sweden. |
| How many employees does Cell Impact have? | As of today, Cell Impact has over 41 employees. |
| Is Cell Impact publicly listed? | Yes, Cell Impact is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Cell Impact? | Cell Impact trades under CI ticker. |
| When did Cell Impact go public? | Cell Impact went public in 2013. |
| Who are competitors of Cell Impact? | Cell Impact main competitors are Mangels, Coil, Nordic Flanges Group, Pipe Works L Girakian. |
| What is the current market cap of Cell Impact? | Cell Impact's current market cap is $8M. |
| What is the current revenue of Cell Impact? | Cell Impact's last fiscal year revenue is $606K. |
| What is the current EV/Revenue multiple of Cell Impact? | Current revenue multiple of Cell Impact is 16.1x. |
| Is Cell Impact profitable? | No, Cell Impact is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.